Panelist
speaker
Moderator
conference Team

Vimal Patel

Director, Cosmos Limited 
Vimal Patel

Mr. Vimal Patel serves as a Managing Director of Cosmos Limited, a leading pharmaceutical manufacturing company in Kenya, producing branded generic pharmaceutical products for both Human and Veterinary use. He obtained his Bachelor’s Degree in Pharmacy –B Pharm (Hons) from Brighton University in London. He attended the Accelerated Development Program at London Business School. In the Early years, Kenya was importing all medicines that were consumed here, it was important that Kenya started making essential pharmaceuticals locally in order to make them readily available and affordable. During his leadership in Cosmos for over 30 years he was able to locally manufacture essential, quality and affordable medicines used to fight major endemic diseases such as malaria, Tuberculosis and AIDS. Cosmos is now making more complex medicines used for treatment of hypertension and diabetes and exporting to 13 countries in Africa. Currently he is also the Chair of Federation of Kenya Pharmaceutical Manufacturers (FKPM) and vice chair Kenya Association of Manufacturers Pharma Sector. Through his Chairmanship of FKPM he has been driving policies through Ministry of Health other government bodies and external bodies such as GIZ, IFC, WHO in making Kenya self-sufficient in production of quality affordable pharmaceutical products and creating jobs.In partnership with Clinton Foundation, Cosmos was able to introduce Oral Rehydration Salts with Zinc to combat diarrhea in young children. This led to a significant drop in child mortality and a very drastic drop in the cost of treatment, less than 1 US. He continues to develop and execute the company’s growth strategy.

Agenda

More Info
Breakout 1
|
Saturday
|
10:15 am
Aldrich 109
Ecosystem Development
Empowering Africa's Pharma Revolution
A discussion on the critical issue of pharmaceutical production on the continent
More Info

Empowering Africa's Pharma Revolution

African nations are on the precipice of momentous changes in the healthcare landscape. Challenges in infectious disease still ravage major segments of the continent while chronic illnesses are emerging as the leading causes of morbidity and mortality. The push for changes, however, has often led to the adoption of partial solutions while the COVID-19 pandemic revealed that the most difficult problems remain unresolved. In this session, we are convening an elite group of professionals, ranging from drug manufacturers, regulators, entrepreneurs, and astute investors to discuss the critical issue of pharmaceutical production on the continent. This session is meticulously designed for decision-makers and innovators seeking to capture tremendous opportunity and make a tangible impact in the healthcare sector. 

America/New_York
Feb 17, 2024 10:15 AM
Aldrich 109